Pharming Group (XAMS:PHARM) Accumulated other comprehensive income (loss) : €8.0 Mil (As of Mar. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Pharming Group Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Pharming Group's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was €8.0 Mil.

Pharming Group's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (€8.4 Mil) to Dec. 2024 (€-0.2 Mil) but then increased from Dec. 2024 (€-0.2 Mil) to Mar. 2025 (€8.0 Mil).

Pharming Group's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (€-8.2 Mil) to Dec. 2023 (€-1.9 Mil) and increased from Dec. 2023 (€-1.9 Mil) to Dec. 2024 (€-0.2 Mil).

Pharming Group Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Pharming Group's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Accumulated other comprehensive income (loss) Chart

Pharming Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

20.23

3.01

-8.25

-1.89

-0.20

Pharming Group Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-3.68	5.94	8.41	-0.20	8.04

Pharming Group Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Pharming Group Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Pharming Group's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (XAMS:PHARM) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

PHAR:USA PHGUF:USA PHARMa:UK 0QCO:UK PHGN:Germany

Address

Darwinweg 24, Leiden, ZH, NLD, 2333 CR

Website

https://www.pharming.com

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Pharming Group Headlines

No Headlines